Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SANGAMO THERAPEUTICS, INC | 10%+ Owner | Common Stock | 17.7M | $6.75M | $0.38 | Sep 26, 2023 | By Biogen MA Inc. |
REATA PHARMACEUTICALS INC | Other* | Class A common stock | 0 | $172.03 | Jul 28, 2023 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGMO | SANGAMO THERAPEUTICS, INC | Sep 26, 2023 | 1 | -$3M | 4 | Sep 28, 2023 | 10%+ Owner |
RETA | REATA PHARMACEUTICALS INC | Jul 28, 2023 | 0 | $0 | 3 | Aug 7, 2023 | Other* |
SGMO | SANGAMO THERAPEUTICS, INC | Aug 29, 2022 | 2 | -$2.66M | 4 | Aug 31, 2022 | 10%+ Owner |
SGMO | SANGAMO THERAPEUTICS, INC | Dec 28, 2021 | 1 | -$23.5K | 4 | Dec 30, 2021 | 10%+ Owner |
SGMO | SANGAMO THERAPEUTICS, INC | Dec 23, 2021 | 2 | -$700K | 4 | Dec 28, 2021 | 10%+ Owner |
SGMO | SANGAMO THERAPEUTICS, INC | Dec 9, 2021 | 1 | -$203K | 4 | Dec 10, 2021 | 10%+ Owner |
SGMO | SANGAMO THERAPEUTICS, INC | Dec 7, 2021 | 2 | -$1.1M | 4 | Dec 9, 2021 | 10%+ Owner |
SGMO | SANGAMO THERAPEUTICS, INC | Dec 1, 2021 | 2 | -$22.2K | 4 | Dec 3, 2021 | 10%+ Owner |
SGMO | SANGAMO THERAPEUTICS, INC | Nov 26, 2021 | 1 | -$248K | 4 | Nov 30, 2021 | 10%+ Owner |